| Literature DB >> 30296479 |
Nandita Khera1, Betty K Hamilton2, Joseph A Pidala3, William A Wood4, Vicky Wu5, Jenna Voutsinas5, Lynn Onstad5, Amin M Alousi6, Raewyn Broady7, George L Chen8, Mukta Arora9, Corey Cutler10, Mary E Flowers5, Alex Ganetsky11, Madan Jagasia12, Philip L McCarthy8, Stefanie Sarantopoulos13, Gregory A Abel10, Navneet S Majhail2, Stephanie J Lee5.
Abstract
Understanding the socioeconomic impact of chronic graft-versus-host disease (GVHD) on affected patients is essential to help improve their overall well-being. Using data from the Chronic GVHD Consortium, we describe the insurance, employment, and financial challenges faced by these patients and the factors associated with the ability to work/attend school and associated financial burdens. A 15-item cross-sectional questionnaire designed to measure financial concerns, income, employment, and insurance was completed by 190 patients (response rate, 68%; 10 centers) enrolled on a multicenter Chronic GVHD Consortium Response Measures Validation Study. Multivariable logistic regression models examined the factors associated with financial burden and ability to work/attend school. The median age of respondents was 56years, and 87% of the patients were white. A higher proportion of nonrespondents had lower income before hematopoietic cell transplantation and less than a college degree. All but 1 patient had insurance, 34% had faced delayed/denied insurance coverage for chronic GVHD treatments, and 66% reported a financial burden. Patients with a financial burden had greater depression/anxiety and difficulty sleeping. Nonwhite race, lower mental functioning, and lower activity score were associated with a greater likelihood of financial burden. Younger age, early risk disease, and higher mental functioning were associated with a greater likelihood of being able to work/attend school. In this multicenter cohort of patients with chronic GVHD, significant negative effects on finances were observed even with health insurance coverage. Future research should investigate potential interventions to provide optimal and affordable care to at-risk patients and prevent long-term adverse financial outcomes in this vulnerable group.Entities:
Keywords: Financial hardship; chronic GVHD; hematopoietic cell transplantation
Mesh:
Year: 2018 PMID: 30296479 PMCID: PMC6445749 DOI: 10.1016/j.bbmt.2018.09.040
Source DB: PubMed Journal: Biol Blood Marrow Transplant ISSN: 1083-8791 Impact factor: 5.742